Paragon Bioservices Appoints John Conner as SVP GMP Manufacturing

NewSpring Healthcare

This article first appeared on PR Newswire on November 22nd, 2016.

BALTIMORE, Nov. 22, 2016 /PRNewswire/ --  A global leader in the manufacturing of biopharmaceuticals, vaccines, and viral vectors announced today the appointment of John Conner to the position of Senior Vice President of GMP Manufacturing.

"We are building a world class GMP team to complement the Company's outstanding pre-clinical capabilities.  John's experience and leadership in growing Cytovance and expanding its service offerings to include commercial manufacturing will be invaluable in supporting Paragon's growth initiatives in GMP vaccine and gene-therapy viral vector manufacturing," stated Peter Buzy, President and CEO of Paragon.  "John's experience is very broad and complements well the wide array of biopharmaceuticals that we manufacture for our clients.  We are excited to have John join our senior team and to be a critical part of the Company's future growth.  We look forward to his contributions as we continue to grow the company to be a world leader in vaccine, live-virus, and recombinant viral vector development and manufacturing." Read more...